Dialysis & Apheresis Market Share & Growth | Forecast 2031

Report Description

Dialysis & Apheresis Market Outlook

The Global Dialysis & Apheresis Market was estimated at USD 19,079.2 Mn in 2022 and is anticipated to reach USD ~34,519.3 Mn by 2031, expanding at a CAGR of 7.1% during the forecast period.

Dialysis is a procedure that facilitates the removal of waste products & excess fluid from the blood of a person when the kidneys stop working properly. It often involves diverting blood to a machine to be cleaned. It involves using a machine to clean the blood and maintain proper electrolyte balance, helping individuals with kidney failure manage their condition and maintain their health.

Get Free Sample Report

If a person’s chronic kidney disease (CKD) reaches end-stage renal disease (ESRD), also known as kidney failure or stage 5 CKD, then kidneys are not able to filter and clean the blood as healthy kidneys do. Waste and toxins build up in the body without treatment. At this point, dialysis treatment is needed to prolong life until a kidney transplant takes place.

According to the United States Renal Data System 2020
1- Nearly 808,000 people in the US are living with End-stage kidney disease (ESKD), with 69% on dialysis and 31% with a kidney transplant.
2- Men are 1.6 times more likely to develop ESKD than women.
3- People of African descent are 4 times more likely to develop ESKD than people of Caucasian descent.
5- Hispanic people and Native Americans are more than twice as likely to develop ESKD.
6- People of Asian origin are 1.4 times likely to develop ESKD.
7- People of African descent make up about 13% of the total population, and account for 30% of people with ESKD in the US.
8- People of African descent are more likely to have ESKD caused by high blood pressure, also called as hypertension, than people of Caucasian descent or Hispanic people.

Macro-economic Factors

Healthcare Spending

Healthcare spending is a significant macroeconomic factor that has a substantial impact on the North America dialysis and apheresis market. The level of healthcare spending directly influences the accessibility and affordability of these treatments.

Increased healthcare spending led to improved healthcare infrastructure, including the availability of specialized clinics, medical equipment, and trained professionals needed for dialysis and apheresis procedures.

For instance, in 2019, Fresenius Medical Care North America (FMCNA) manufactured 57.6 million dialyzers in the US. Additionally, FMCNA operates a network of approximately 4000 outpatient dialysis centers out of that more than 2500 are in the US. High healthcare spending often translates to improved insurance coverage and accessible healthcare services.

Regulatory Framework

The regulatory environment is a crucial macroeconomic factor that significantly impacts the dialysis and apheresis market in Europe. Regulations govern the approval and licensing of medical devices and treatments. A favorable regulatory environment expedites the introduction of products and therapies to the market, promoting innovation and expanding patient access to advanced treatments. Stringent regulations increase compliance costs for manufacturers and healthcare facilities.

For instance, The Medical Devices Regulation (MDR), is a regulation that applicable since May 26, 2021, and replaces the previous directives on medical devices and active implantable medical devices. It aims to ensure a high level of safety, quality, and performance of medical devices in the market in the EU. It introduces new requirements for manufacturers, authorities, and other stakeholders.

Dialysis & Apheresis Market Dynamics

Market Driver- Increasing Prevalence of Chronic Kidney Disease

Increasing prevalence of chronic kidney disease (CKD) is driving the global dialysis and apheresis market, as CKD often progresses to end-stage renal disease (ESRD), where the kidneys are no longer able to adequately filter waste and excess fluids from the blood.

According to Centers for Disease Control and Prevention, more than 1 in 7 adults in the US, which accounts to about 35.5 million people or 14%, were estimated to have CKD in 2023. Additionally, dialysis is crucial for managing ESRD by performing the kidney’s function artificially. Rising cases of CKD is boosting the demand for dialysis and apheresis procedures.

Market Driver- Growing Number of Injury Cases

Growing number of injury cases is positively impacting the dialysis and apheresis market. Traumatic injuries, such as accidents or severe burns, significantly lead to acute kidney injury (AKI). Dialysis and apheresis are often used to manage AKI, driving the demand for these procedures in case of sudden kidney dysfunction.

Additionally, injuries result in blood-related disorders that require apheresis procedures to remove abnormal blood components, contributing to the demand for apheresis procedures. For instance, as per Personal Injury Statistics 2023, medical treatment is required for around 39.5 million personal injury cases in the US every year, which is roughly 126.3 cases per 1000.

Market Restraint- Lack of Awareness about Kidney Diseases

Lack of awareness about kidney disease is restraining the dialysis and apheresis market. Lack of awareness about kidney disease leads to delayed diagnosis, as individuals are not able to recognize the early signs and symptoms. Lack of awareness regarding the risk factors and importance of early detection leads to reduced demand for screening & tests that identify kidney problems at an early stage.

This leads to underutilization of available treatment options. Many people are reluctant to undergo these procedures. Disease awareness remains profoundly low, despite the rising prevalence of CKD. Only 6% of the general population and 10% of the high-risk population are aware of their CKD statuses globally.

Market Opportunity- Advancement in Technology

Technological advancements offer significant opportunities for the dialysis and apheresis market. Advanced technologies enhance the effectiveness of dialysis and apheresis treatments. Wearable and portable dialysis devices, membrane materials, and treatment protocols lead to the efficient removal of waste products, toxins, and unwanted substances from blood, resulting in good patient outcomes.

Moreover, technological advancements allow for personalized treatment approaches. New technologies are anticipated to improve the overall treatment experience of the patients. Companies strive to innovate their related products in order to compete in the market.

Scope of Dialysis & Apheresis Market Report           

The report on the Global Dialysis & Apheresis Market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Dialysis & Apheresis Market Segmental Outlook

Based on Type, the market is segmented into Devices and Consumables. The Devices segment is expected to hold a considerable share of the market during the forecast, due to the growing number of chronic kidney diseases (CKD) globally. This is boosting the need for dialysis and apheresis procedures and the devices involved in these procedures.

According to National Library of Medicine in 2022, chronic kidney disease is a progressive condition that affects >10% of the general population globally, amounting to >800 million individuals. This growing figure fuels the demand for dialysis and apheresis devices, as prevailing chronic kidney disease requires dialysis treatment.

Get Free Sample Report

On the basis of end-use, the market is fragmented into Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare. The Hospitals segment holds a key share of the market, owing to the growing demand for dialysis and apheresis procedures from various parts of the world. Growing number of people suffering from kidney-related diseases is driving the hospitals segment.

According to Single Care Administrators in 2023, an estimated 1 million people worldwide die from untreated kidney failure each year. Globally, CKD rates are increasing, as Saudi Arabia and Belgium are estimated to have the highest predicted CKD rates among high-income countries, at 24% of the population. Norway and the Netherlands are among the lowest-ranking countries for CKD.

Get Free Sample Report

Regional Outlook

Based on regions, the market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a significant share of the market in 2022, due to advancement in medical technology in the region. Europe held a significant market share in 2022, owing to continuous focus on innovative product launches in the region.

Get Free Sample Report

Key Benefits for Industry Participants & Stakeholders

• In-depth Analysis of the Global Dialysis & Apheresis Market

• Historical, Current, and Projected Market Size in Terms of Value

• Potential & Niche Segments and Regions Exhibiting Promising Growth Covered

• Industry Drivers, Restraints, and Opportunities Covered in the Study

• Recent Industry Trends and Developments

• Competitive Landscape & Strategies of Key Players

• Neutral Perspective on Global Dialysis & Apheresis Market PerProduct Typeance